Pulmatrix, Inc. - Common Stock (PULM)

Pulmatrix Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for respiratory diseases

The company utilizes its proprietary technology platform to create new treatments that target and modulate the underlying mechanisms of respiratory conditions, including chronic obstructive pulmonary disease (COPD) and asthma. Pulmatrix aims to improve the lives of patients through the development of novel inhaled therapeutics that enhance drug delivery and optimize treatment outcomes. With a commitment to advancing respiratory health, Pulmatrix is dedicated to bringing transformative solutions from the laboratory to the patients who need them.